Table 2 Baseline characteristics of study population (n = 300)
Age (years) | 55 ± 16 |
Gender (male, %) | 179 (59.7%) |
Weight (kg) | 83 ± 20 |
Length (cm) | 171 ± 10 |
BMI (kg / m 2 ) | 28.2 ± 5.9 |
BSA (m 2 ) | 2.0 ± 0.3 |
LVEDVi (mL/m 2 ) | 92 ± 30 |
LVESVi (mL/m 2 ) | 48 ± 30 |
LVSVi (mL/m 2 ) | 44 ± 10 |
LVEF (%) | 51 ± 14 |
RVEF (%) | 55 ± 10 |
Known significant CAD (n, %) | 68 (22.7%) |
Previous myocardial infarction (n, %) | 48 (16.0%) |
Previous PCI (n, %) | 32 (10.7%) |
Previous CABG (n, %) | 10 (3.3%) |
Indication for CMR (n, %) | |
Cardiomyopathy | 172 (57.3%) |
Myocardial infarction / viability | 52 (17.3%) |
Myocarditis | 33 (11.0%) |
Aortic pathology | 3 (1.0%) |
Valvular disease | 2 (0.7%) |
Pericardial disease | 3 (1.0%) |
Cardiac mass | 1 (0.3%) |
Stress perfusion | 102 (34.0%) |
Final diagnosis (n, %) | |
Normal | 93 (31.0%) |
Non-ischemic cardiomyopathy | 80 (26.7%) |
Myocardial infarction | 87 (29.0%) |
Ischemia | 34 (11.3%) |
Myocarditis | 17 (5.7%) |
Aortic pathology | 2 (0.7%) |
Valvular disease | 4 (1.3%) |
Pericardial disease | 4 (1.3%) |
Cardiac mass | 0 (0%) |
Other | 1 (0.3%) |